Sensei Biotherapeutics, Inc. - Common Stock (NQ:SNSE)
9.090
+0.250
(+2.83%)
Streaming Delayed Price
Updated: 4:00 PM EST, Feb 12, 2026
Add to My Watchlist
All News about Sensei Biotherapeutics, Inc. - Common Stock
Egle Therapeutics Appoints John Celebi as Chief Executive Officer
January 07, 2026
From Egle Therapeutics
Via GlobeNewswire
Sensei (SNSE) Q2 Loss Narrows 31% ↗
August 06, 2025
Via The Motley Fool
Topics
Intellectual Property
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
|
| ||||||